Form 4: Linde PLC Executive Kelcey E. Hoyt Reports Changes in Beneficial Ownership
SEC Form 4
Kelcey E. Hoyt, a Principal Accounting Officer at Linde PLC, filed a Form 4 detailing transactions involving ordinary shares, restricted stock units, and stock options.
Summary
- On May 1, 2024, Kelcey E. Hoyt, Principal Accounting Officer of Linde PLC, reported changes in beneficial ownership.
- The report includes the acquisition of 155 Restricted Stock Units (RSUs) that will vest and payout on or about May 1, 2027.
- Hoyt also directly owns 16,691.947 ordinary shares and indirectly owns 545.82 shares through a 401(k).
- The report details various stock options with different exercise prices and vesting schedules, ranging from options granted in 2019 to 2025.
- Hoyt also holds 265, 320, and 310 Restricted Stock Units that will vest in March 2027, March 2026, and March 2025 respectively.
- Additionally, Hoyt owns 131.795 Deferred Stock Units acquired under the Compensation Deferred Plan.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Positives
- The reporting of transactions is in compliance with SEC regulations.
- The document provides transparency into the executive's holdings and potential future ownership.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency to investors regarding insider transactions.
Stakeholder Impact
- Shareholders gain insight into the holdings of a key executive.
Key Dates
| Date | Description |
|---|---|
| 02/27/2019 | Date of grant for stock options exercisable in three equal annual installments beginning on the first anniversary of the grant date. |
| 03/20/2020 | Date of grant for stock options vesting over three years in three consecutive equal annual installments beginning on March 20, 2020. |
| 03/09/2021 | Date of grant for stock options vesting over three years in three consecutive equal annual installments beginning on March 9, 2021. |
| 03/08/2022 | Date of grant for stock options vesting over three years in three consecutive equal annual installments beginning on March 8, 2022. |
| 03/07/2023 | Date of grant for stock options vesting over three years in three consecutive equal annual installments beginning on March 7, 2023. |
| 03/07/2024 | Date of grant for stock options vesting over three years in three consecutive equal annual installments beginning on March 7, 2024. |
| 05/01/2024 | Date of transaction and reporting of changes in beneficial ownership, including acquisition of Restricted Stock Units. |
| 03/07/2025 | Date of grant for stock options vesting over three years in three consecutive equal annual installments beginning on March 7, 2025. |
| 03/07/2025 | Vesting start date for Restricted Stock Units that will vest in full and payout on or about March 7, 2025. |
| 03/07/2026 | Vesting start date for Restricted Stock Units that will vest in full and payout on or about March 7, 2026. |
| 03/07/2027 | Vesting start date for Restricted Stock Units that will vest in full and payout on or about March 7, 2027. |
| 05/01/2027 | Date on or about when Restricted Stock Units will vest in full and payout. |
| 02/27/2028 | Expiration date for stock options granted on 02/27/2019. |
| 03/20/2029 | Expiration date for stock options granted on 03/20/2020. |
| 03/09/2030 | Expiration date for stock options granted on 03/09/2021. |
| 03/08/2031 | Expiration date for stock options granted on 03/08/2022. |
| 03/07/2032 | Expiration date for stock options granted on 03/07/2023. |
| 03/07/2033 | Expiration date for stock options granted on 03/07/2024. |
| 03/07/2034 | Expiration date for stock options granted on 03/07/2025. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.